Literature DB >> 8872544

Bipolar hip replacement in sickle cell disease.

B K Sanjay1, P G Moreau.   

Abstract

A retrospective study is presented of 26 uncemented bipolar hip replacements for avascular necrosis of the femoral head due to sickle cell disease which were carried out between 1987 and 1992. All patients were treated according to a protocol. The average follow up was 4.6 years (range 2.1 to 7 years). After operation, the average Harris hip score improved from 36 to 88. Bone culture was positive for bacterial growth in 4 hips (coagulase negative staphylococcus in 3). There was progressive wear of acetabular articular cartilage in 2 cases, but no clinical or radiological evidence of loosening of the femoral stem. Seventeen complications occurred in 9 of the 21 patients (5 in one patient). A longitudinal split of the femur was the commonest operative complication and occurred in 5 hips. Femoral medullary sclerosis was seen in 8 cases. Patients with sickle cell disease have a high risk of complications, but this type of hip replacement should be considered in carefully selected patients who have avascular necrosis of the femoral head.

Entities:  

Mesh:

Year:  1996        PMID: 8872544     DOI: 10.1007/s002640050068

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  6 in total

1.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

Review 2.  [Surgical treatment concepts for femoral head necrosis].

Authors:  D von Stechow; P Drees
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

3.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

4.  Management of femoral head osteonecrosis: Current concepts.

Authors:  Sujit Kumar Tripathy; Tarun Goyal; Ramesh Kumar Sen
Journal:  Indian J Orthop       Date:  2015 Jan-Feb       Impact factor: 1.251

5.  Revision hip arthroplasty in sickle cell disease.

Authors:  Aydýner Kalacý; Cenk Ozkan; Emre Toğrul
Journal:  Ann Saudi Med       Date:  2007 Mar-Apr       Impact factor: 1.526

6.  Re: The adult hip joint in Saudi Arabia.

Authors:  Mohammed Moussa; Abdulla Alumran
Journal:  Ann Saudi Med       Date:  2007 Mar-Apr       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.